Innovent Biologics, Inc. carries a market capitalization of 132.61B, placing it among publicly traded companies globally.
| Market Cap | 132.61B |
| Enterprise Value | N/A |
Innovent Biologics, Inc.'s stock has declined approximately -5.26642% over the past 52 weeks. The 50-day moving average sits at 84.56, while the 200-day moving average is 87.08.
| Beta (5Y) | N/A |
| 52-Week Price Change | -5.26642% |
| 50-Day Moving Average | 84.56 |
| 200-Day Moving Average | 87.08 |
| Average Volume (20 Days) | N/A |